Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.

Ranking 14th among prescriptions (as per SMSRC May 16' )and 19th in sales (as per AWACS MAT May’16) , Micro’s brand portfolio includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management.

The company is also at the forefront in social contribution, striving to be a model corporate citizen in terms of Environmental Protection & Social Initiatives with significant contributions in the areas of education and health. Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Backed by a profound and resolute vision, we now have our eyes set on attaining the $1 billion mark by 2020

Business Development

Micro Labs is committed to opportunities and partnerships that drive growth and value

Ranked among the top 19 pharmaceutical companies in India, Micro Labs has presence in over 40 countries with ground level operations in 15 countries, exporting formulations in every therapeutic segment.

Our global presence is supported by 14 world class manufacturing facilities approved by USFDA,UK-MHRA,Health Canada, WHO,TGA Australia, MCC-South Africa & Medsafe New Zealand and 3 R&D centres in Bangalore and Mumbai with over 250 experienced scientists.

Our global growth strategy is focused on the key principles of internal product development; strategic alliances; and select mergers/acquisitions of products, technologies and companies.

As we expand our global pharmaceuticals business, Micro Labs is committed to identifying opportunities that fit our capabilities, enhance our corporate goals and strengthen our competitive position.

Micro Labs is uniquely placed in our industry -We are recognised as one of the leaders in healthcare and as a pioneer in seeking cutting edge technologies and world-class quality. We are a fully integrated pharmaceutical business capable of developing, manufacturing, marketing and distributing products on its own, we also recognize the value of collaboration.

By leveraging our combined assets, expertise and capabilities, we can lower costs, increase productivity and, ultimately, produce a medicine that helps patients.

Micro Labs takes a strategic approach to business development activities, ensuring that the expectations of our partners are aligned with our own. Micro Labs offers its partners strong R&D and commercial resources as well as the experience needed to guide products through the regulatory process.

However, building a next generation pharmaceutical company requires new technologies, new ideas, new products and new insights. These can be found anywhere and everywhere in the world.

If you have innovations or ideas that will help transform our industry we want to hear from you. We invite academic institutions and pharmaceutical or biotech companies that share our goal of helping to address unmet medical needs to contact us with proposals.

Global Presence and International Formulations

1. The Global Footprint of Micro Labs Limited

A Vibrant Presence in over 30 countries with ground level operations in 15 countries, exporting all major dosages on most of the therapeutic segments.

Poised to have a quantum leap in our global operations, with implementation of our growth strategies.

Own marketing, regulatory & sales operations in the following Geographies


  • South East - Thailand, Myanmar, Cambodia, Vietnam
  • Far East - Taiwan, Srilanka, Nepal, Philippines, Malaysia, Indonesia, Singapore
  • Middle East - Yemen, Iraq, Sudan, UAE


  • CIS - Azerbaijan, Russia, Kazakhstan, Ukraine, Moldova, Belarus


  • South Africa
  • West Africa - Senegal, Nigeria, Ivory coast, Cameroon
  • East Africa - Kenya, Uganda, Tanzania
  • North Africa - Algeria, Libya

South & Central America

  • Mexico, Guatemala, Panama, Dominican Republic, Peru

Future plans to spread its wings in countries like Canada, South Africa, UAE, etc.

The company has established wholly owned subsidiaries in the USA (Micro Labs USA Inc.) , UK (Brown & Burk UK Ltd), Germany (Micro Labs GmbH), Australia (Micro Labs Pty Ltd) and Nigeria (Micro Nova Pharmaceuticals Ind Ltd).

2. Our Therapeutic list in Regulatory market:

  • Lipid Lowering Agents
  • Anti-bacterials
  • Anti-depressants
  • Oral Hypoglycemic Agents (Diabetologicals)
  • Anti-hypertensives
  • Anti-Inflammatories(NSAIDs)
  • Anti-ulcerants
  • Anti-Allergics
  • Opthalmologicals
  • Anti-epileptics

3. 14 World-class State-of-the-art manufacturing facilities at the following locations

  • 3 sites in Hosur at Tamil Nadu – South India
  • 7 sites in and around Bangalore – South India
  • 1 site in Pondicherry – South India
  • 1 site in Goa – Western India
  • 1 site in Baddi – Northern India
    • 1 site in Sikkim- Northern India

These globally certified facilities have been Approved by the various regulatory authorities:

  • Food & Drugs Control Administration (FDA), US
  • Medicines and Healthcare products Regulatory Agency (MHRA), UK
  • Health Canada
  • World Health Organisation (WHO),
  • Therapeutic Goods Authority (TGA), Australia
  • Medsafe, New Zealand
  • Ministry of Health (MoH) of may countries of the emerging market.

4. Surana College :

5. Jain Temple Complex :

The Magnificent Jain Shrine complex called Shri Parshwa-Sushil Dham has been built and is Managed by the Surana family in Attibele at Bangalore,Karnataka- in memory of the Jain Saint Sushil Suriji

6. CMD Profile :

Mr.Dilip Surana- Chairman and Managing Director of Micro Labs Limited has many Awards & Accolades to his name :

  • Ranked 72rd position on Forbes magazine’s list of 100 richest Indians with an estimated net worth of over $1.6 billion.
  • Instrumental in Micro Labs bagging the coveted “Pharma Company of the year Award” in the year 2009.
  • Awarded ‘Dynamic Entrepreneur of the year 2010’, Most Dynamic Entrepreneur of the Year’ 2013 at 4th Annual India Leadership Conclave and Indian Affairs Business Leadership Awards and ‘Entrepreneur of the year’ 2014.
  • Honored as the ‘Great Son of Karnataka’ by Governor of Karnataka his Excellency HR Bhardwaj in 2011.
  • Recognized as a ‘Paul Harris Fellow’ by the Rotary Foundation Of Rotary International, in appreciation of tangible and significant assistance given for the furtherance of better understanding and friendly relations among peoples of the world
  • Granted 21 external CME credits by EBAC(The European Board for Accreditation in Cardiology) at Amsterdam, Netherlands for participation in ESC Congress 2013

7. Quality :

  • Regular IDMA award winner
  • Manufacture of our innovative products are ably supported by an intelligent Quality Management Systems implemented to perfection

8. Brand Awards :

  • Dolo 650 won the Brand of the Year 2014 GOLD award and Amlong won Brand of the Year 2014 BRONZE Award at AWACS Marketing Excellence Awards 2014
  • Brand Dolo 650 awarded as ‘Brand of the Year 2013’ at 6th Annual Pharmaceutical Leadership Summit 2013
  • Caripill awarded as ‘Emerging Brand of the Year 2015’

9. Caripill :

  • Caripill was Awarded as ‘Emerging Brand of the Year 2015’
  • Excellence in Brand/Product - Prescription Drug

10. Dolo-650

  • Dolo 650 won the Brand of the Year 2014 GOLD award Award at AWACS Marketing Excellence Awards 2014
  • Brand Dolo 650 awarded as ‘Brand of the Year 2013’ at 6th Annual Pharmaceutical Leadership Summit 2013